相似文献
1
Reeling from news that reelin defends the brain against Alzheimer's.
Cell Rep Med. 2023 Jul 18;4(7):101111. doi: 10.1016/j.xcrm.2023.101111.
2
Reelin links Apolipoprotein E4, Tau, and Amyloid-β in Alzheimer's disease.
Ageing Res Rev. 2024 Jul;98:102339. doi: 10.1016/j.arr.2024.102339. Epub 2024 May 14.
3
Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer's disease.
FASEB J. 2018 Jul;32(7):3536-3546. doi: 10.1096/fj.201700736RR. Epub 2018 Feb 9.
4
The involvement of Reelin in neurodevelopmental disorders.
Neuropharmacology. 2013 May;68:122-35. doi: 10.1016/j.neuropharm.2012.08.015. Epub 2012 Sep 7.
5
Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer's disease.
Nat Commun. 2014 Mar 6;5:3443. doi: 10.1038/ncomms4443.
6
Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.
Neurobiol Dis. 2010 Mar;37(3):682-91. doi: 10.1016/j.nbd.2009.12.006. Epub 2009 Dec 16.
7
Disease-Specific Changes in Reelin Protein and mRNA in Neurodegenerative Diseases.
Cells. 2020 May 19;9(5):1252. doi: 10.3390/cells9051252.
8
Genetic analysis of the RELN gene: Gender specific association with Alzheimer's disease.
Psychiatry Res. 2015 Dec 15;230(2):716-8. doi: 10.1016/j.psychres.2015.09.021. Epub 2015 Sep 13.
9
Re-evaluation of protease activity of reelin.
Biol Pharm Bull. 2010;33(6):1047-9. doi: 10.1248/bpb.33.1047.
10
Sexually Dimorphic Expression of Reelin in the Brain of a Mouse Model of Alzheimer Disease.
J Mol Neurosci. 2017 Mar;61(3):359-367. doi: 10.1007/s12031-016-0865-x. Epub 2016 Nov 19.
引用本文的文献
1
Biomolecular Aspects of Reelin in Neurodegenerative Disorders: An Old Candidate for a New Linkage of the Gut-Brain-Eye Axis.
Int J Mol Sci. 2025 Jul 30;26(15):7352. doi: 10.3390/ijms26157352.
2
Protective Genes Against Alzheimer's Disease: Case Review and Therapeutic Implications.
Dement Neurocogn Disord. 2025 Apr;24(2):75-90. doi: 10.12779/dnd.2025.24.2.75. Epub 2025 Apr 8.
3
APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.
Mol Psychiatry. 2025 Apr 30. doi: 10.1038/s41380-025-03036-7.
本文引用的文献
1
Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man.
Nat Med. 2023 May;29(5):1243-1252. doi: 10.1038/s41591-023-02318-3. Epub 2023 May 15.
2
Synaptic resilience is associated with maintained cognition during ageing.
Alzheimers Dement. 2023 Jun;19(6):2560-2574. doi: 10.1002/alz.12894. Epub 2022 Dec 22.
3
Whole genome analysis in APOE4 homozygotes identifies the DAB1-RELN pathway in Alzheimer's disease pathogenesis.
Neurobiol Aging. 2022 Nov;119:67-76. doi: 10.1016/j.neurobiolaging.2022.07.009. Epub 2022 Jul 29.
4
Genetic variants and functional pathways associated with resilience to Alzheimer's disease.
Brain. 2020 Aug 1;143(8):2561-2575. doi: 10.1093/brain/awaa209.
5
Clusterin accumulates in synapses in Alzheimer's disease and is increased in apolipoprotein E4 carriers.
Brain Commun. 2019;1(1):fcz003. doi: 10.1093/braincomms/fcz003. Epub 2019 Jun 24.
6
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.
Nat Med. 2019 Nov;25(11):1680-1683. doi: 10.1038/s41591-019-0611-3. Epub 2019 Nov 4.
7
Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Brain. 2013 Aug;136(Pt 8):2510-26. doi: 10.1093/brain/awt171. Epub 2013 Jul 3.
8
Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β.
Brain. 2012 Jul;135(Pt 7):2155-68. doi: 10.1093/brain/aws127. Epub 2012 May 26.
9
Reelin, lipoprotein receptors and synaptic plasticity.
Nat Rev Neurosci. 2006 Nov;7(11):850-9. doi: 10.1038/nrn2009.
10
Neuropathology of older persons without cognitive impairment from two community-based studies.
Neurology. 2006 Jun 27;66(12):1837-44. doi: 10.1212/01.wnl.0000219668.47116.e6.
Zotero 插件